{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-009155","form_type":"8-K","ticker":"MIRA","cik":"0001904286","company_name":"MIRA PHARMACEUTICALS, INC.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.438941+00:00","generated_at":"2026-05-22T05:40:29.669671+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"MIRA Pharmaceuticals to acquire SKNY; combined enterprise value over $60M","bullets":["Board unanimously approved definitive agreement to acquire SKNY on April 30, 2025.","Third-party valuation assigned SKNY enterprise value of ~$30.5M; MIRA ~$30M.","SKNY to contribute $5M in assets or cash at closing with no contingencies.","Combined enterprise value exceeds $60M, creating a broader platform targeting obesity and nicotine dependence.","MIRA preparing to file proxy statement to seek shareholder approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-009155","json":"https://secwatch.observer/filing/0001641172-25-009155.json","markdown":"https://secwatch.observer/filing/0001641172-25-009155.md","text":"https://secwatch.observer/filing/0001641172-25-009155.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1904286/000164117225009155/0001641172-25-009155-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1904286/000164117225009155/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T05:40:29.669671+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}